Test Background Carbamezepine is indicated for the treatment of partial and secondary generalised tonic-clonic seizures, primary generalised tonic-clonic seizures; trigeminal neuralgia and prophylaxis of bipolar disorder unresponsive to lithium.
Clinical Indications Therapeutic drug monitoring Suspected toxicity (particularly in fitting patients)
Reference Range 4-12 mg/L
Sample Required SST (gold top) or serum (red top)
Sample Volume 0.5 mL pre-dose trough sample
Turnaround Time 2 days